PURPOSE: The aim of this study was to compare the restaging accuracy of repeat fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) scan with pelvic magnetic resonance imaging (MRI) in patients with rectal cancer who have undergone preoperative chemoradiation. METHODS: One hundred and eighty-one consecutive patients with locally advanced rectal cancer who underwent a total mesorectal excision after preoperative chemoradiation were prospectively enrolled. All the patients underwent FDG-PET/CT and pelvic MRI before chemoradiation and 5 weeks after the completion of chemoradiation. We evaluated the measurements of the FDG uptake (SUV(max)) and the percentage of SUV(max) difference (Response Index = RI) between the pre- and postchemoradiation FDG-PET/CT scans. The accuracy of repeat FDG-PET/CT and pelvic MRI for predicting pathologic CR were compared. RESULTS: The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of pelvic MRI for predicting pathologic CR were 38.5, 58.1, 13.3, 84.9, and 55.2%, respectively. In terms of FDG-PET/CT, pretreatment tumor size and pathologic stage were significantly correlated with the RI values. Using a RI value of 63.6% as the cutoff threshold, it was possible to discriminate the CR from the non-CR with a sensitivity of 73.1%, a specificity of 64.5%, a PPV of 25.7%, a NPV of 93.5%, and an accuracy of 65.7% (area under the curve = 0.723, 95% confidence interval 0.619-0.828, P < 0.001). CONCLUSIONS: The accuracy of FDG-PET/CT restaging is superior to that of MRI staging for predicting pathologic CR in irradiated rectal cancer. An NPV of 93.5% indicates that FDG-PET/CT can rule out the pathologic CR.
PURPOSE: The aim of this study was to compare the restaging accuracy of repeat fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) scan with pelvic magnetic resonance imaging (MRI) in patients with rectal cancer who have undergone preoperative chemoradiation. METHODS: One hundred and eighty-one consecutive patients with locally advanced rectal cancer who underwent a total mesorectal excision after preoperative chemoradiation were prospectively enrolled. All the patients underwent FDG-PET/CT and pelvic MRI before chemoradiation and 5 weeks after the completion of chemoradiation. We evaluated the measurements of the FDG uptake (SUV(max)) and the percentage of SUV(max) difference (Response Index = RI) between the pre- and postchemoradiation FDG-PET/CT scans. The accuracy of repeat FDG-PET/CT and pelvic MRI for predicting pathologic CR were compared. RESULTS: The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of pelvic MRI for predicting pathologic CR were 38.5, 58.1, 13.3, 84.9, and 55.2%, respectively. In terms of FDG-PET/CT, pretreatment tumor size and pathologic stage were significantly correlated with the RI values. Using a RI value of 63.6% as the cutoff threshold, it was possible to discriminate the CR from the non-CR with a sensitivity of 73.1%, a specificity of 64.5%, a PPV of 25.7%, a NPV of 93.5%, and an accuracy of 65.7% (area under the curve = 0.723, 95% confidence interval 0.619-0.828, P < 0.001). CONCLUSIONS: The accuracy of FDG-PET/CT restaging is superior to that of MRI staging for predicting pathologic CR in irradiated rectal cancer. An NPV of 93.5% indicates that FDG-PET/CT can rule out the pathologic CR.
Authors: Corneline J Hoekstra; Sigrid G Stroobants; Egbert F Smit; Johan Vansteenkiste; Harm van Tinteren; Pieter E Postmus; Richard P Golding; Bonne Biesma; Frans J H M Schramel; Nico van Zandwijk; Adriaan A Lammertsma; Otto S Hoekstra Journal: J Clin Oncol Date: 2005-11-20 Impact factor: 44.544
Authors: Marije P van der Paardt; Marjolein B Zagers; Regina G H Beets-Tan; Jaap Stoker; Shandra Bipat Journal: Radiology Date: 2013-06-25 Impact factor: 11.105
Authors: Skandan Shanmugan; Rodrigo Arrangoiz; James R Nitzkorski; Jian Q Yu; Tianyu Li; Harry Cooper; Andre Konski; Jeffrey M Farma; Elin R Sigurdson Journal: Ann Surg Oncol Date: 2012-03-07 Impact factor: 5.344
Authors: J M C Yeung; V Kalff; R J Hicks; E Drummond; E Link; Y Taouk; M Michael; S Ngan; A C Lynch; A G Heriot Journal: Dis Colon Rectum Date: 2011-05 Impact factor: 4.585
Authors: Felipe A Calvo; Marta Domper; Raúl Matute; Raúl Martínez-Lázaro; José A Arranz; Manuel Desco; Emilio Alvarez; José Luis Carreras Journal: Int J Radiat Oncol Biol Phys Date: 2004-02-01 Impact factor: 7.038
Authors: Teresa Martín-Aragón; Javier Serrano; Juana Benedí; Rosa M Meiriño; Pilar García-Alonso; Felipe A Calvo Journal: J Gastrointest Oncol Date: 2018-08
Authors: Antonella Petrillo; Roberta Fusco; Mario Petrillo; Vincenza Granata; Paolo Delrio; Francesco Bianco; Biagio Pecori; Gerardo Botti; Fabiana Tatangelo; Corradina Caracò; Luigi Aloj; Antonio Avallone; Secondo Lastoria Journal: Oncotarget Date: 2017-01-31